M
Matti Jauhiainen
Researcher at University of Helsinki
Publications - 182
Citations - 9890
Matti Jauhiainen is an academic researcher from University of Helsinki. The author has contributed to research in topics: Phospholipid transfer protein & Cholesterol. The author has an hindex of 53, co-authored 179 publications receiving 9535 citations.
Papers
More filters
Journal ArticleDOI
Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study
Georg Alfthan,Juha Pekkanen,Matti Jauhiainen,Janne Pitkäniemi,Matti K. Karvonen,J. Tuomilehto,Jukka T. Salonen,Christian Ehnholm +7 more
TL;DR: The results of this prospective population-based study do not support the hypotheses that serum homocysteine or Lp(a) are risk factors for atherosclerotic disease and may be due to the exceptionally low gene frequency predisposing to homocysteinemia in Finland.
Journal ArticleDOI
Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants.
Matti Jauhiainen,Pekka Koskinen,Christian Ehnholm,M. Heikki Frick,Matti Mänttäri,Vesa Manninen,Jussi K. Huttunen +6 more
TL;DR: It is concluded that in the Helsinki Heart Study cohort the serum Lp(a) level was not a predictor of future coronary events.
Journal ArticleDOI
Human plasma phospholipid transfer protein causes high density lipoprotein conversion.
TL;DR: It is demonstrated that PLTP can act like the putative conversion factor and has the ability to convert HDL3 into populations of larger and smaller HDL particles.
Journal ArticleDOI
Stearic acid, trans fatty acids, and dairy fat: effects on serum and lipoprotein lipids, apolipoproteins, lipoprotein(a), and lipid transfer proteins in healthy subjects
TL;DR: High amounts of trans fatty acids had more adverse effects on lipoproteins than did equal amounts of stearic acid and dairy fat, and dietary fats low in both saturated fatty acids and trans fatty fatty acids should be favored.
Journal ArticleDOI
Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis.
Roland Klingenberg,Norbert Gerdes,Robert M. Badeau,Anton Gisterå,Daniela Strodthoff,Daniel F. J. Ketelhuth,Anna M. Lundberg,Mats Rudling,Stefan K. Nilsson,Gunilla Olivecrona,Stefan Zoller,Christine Lohmann,Thomas F. Lüscher,Matti Jauhiainen,Tim Sparwasser,Göran K. Hansson +15 more
TL;DR: In this article, the authors support the use of regulatory T cells (Tregs) as inhibitors of atherosclerosis, however, the mechanistic properties of Tregs are unknown.